Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study (Q42614878)
Jump to navigation
Jump to search
scientific article published on 19 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study |
scientific article published on 19 August 2013 |
Statements
1 reference
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study (English)
1 reference
1 reference
1 reference
1 reference
Xavier Pivot
1 reference
Volkmar Müller
1 reference
Sunil Verma
1 reference
Guillermo López-Vivanco
1 reference
Valerie Jenkins
1 reference
Nana Scotto
1 reference
Stuart Osborne
1 reference
PrefHer Study Group
1 reference
19 August 2013
1 reference
1 reference
Identifiers
1 reference